2
24. 1. 2022.
HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome
HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više